Preparation and In Vitro Release of Alginate/Chitosan Microparticles Containing α-Glucosidase Inhibiting Peptide

Abstract:

Alginate-chitosan multilayer beads containing α-glucosidase inhibiting peptide (GIP) from Ruditapes philippinarum were prepared to develop stable, non-toxic microcapsules. The optimal conditions were alginate concentration (w/v) 1.0%, alginate/GIP ratio (w/w) 1:5, calcium chloride concentration (w/v) 5% and chitosan concentration (w/v) 2.0%, which were obtained through single factor tests and orthogonal experiments. Under the conditions, the encapsulation efficiency (EE%) was 67.21% and the drug-loading percentage was 33.67%.According to the release study, the release rate of GIP was lower than 30% after incubation in simulated gastric fluid (SGF) for 3h and the rate was higher than 70% after incubation in simulated intestinal fluid (SIF) for 5h. The inhibiting rate was 25.13% after treatment in SIF when the concentration of GIP was 10mg/mL. Accordingly,the microcapsules prepared in this paper are acid resistant and therefore can be given orally.

• Periodical: Advanced Materials Research (Volumes 926-930)
• Pages: 1005-1009
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.926-930.1005
• Online since: May 2014
• Authors: Wen Jie Jiang, Zhi Bo Li*, Yan Xia Qi, Qian Cheng Zhao
• Keywords: Alginate, Controlled Release, Microcapsule, α-Glucosidase Inhibiting Peptide

References

[1] Shimizu, M., Fitzsimmons and R. C., Nakai, S: Journal of Food Science, Vol. 53 (1988), No. 5 pp.1360-1366.

[2] Y. Xiao, L.J. Li and Y.N. Jin et al: Appl Biochem Biotechnol, Vol. 159 (2009), pp.778-787.

[3] C.M. Xiao, F. Sun: 2013. Carbohydrate Polymers, Vol. 98 (2013), p.1366–1370.

[4] Y.H. Lin, H.F. Liang and C.K. Chung, et al: Biomaterials, Vol. 26 (2005), p.2105–2113.

[5] Y. Zhang, S.J. Ge and Z. Jiang, et al: Journal of Northeast Agricultural University, Vol. 44 (2013) No. 8, pp.23-28.

[6] Ant onio J. Ribeiro, Catarina Silva and Domingos Ferreira, et al: European Journal of Pharmaceutical Sciences, Vol. 25 (2005), p.31–40.

[7] Anil K. Anal, Willem F. Stevens: International Journal of Pharmaceutics, Vol. 290 (2005), p.45–54.

[8] Sevgi Takka, Aybige Gürel: AAPS PharmSciTech, Vol. 1 (2010) No. 11, pp.460-466.

[9] L.H. Guo, Y. Chen and X.M. Li, et al: Food Research and Development, Vol. 4 (2013), pp.61-64.

[10] Bojan alija, Nebojsa Cekia and Snezana Savic, et al: Arch Pharm Res, Vol. 6 (2011) No. 34, pp.919-929.